Literature DB >> 7080097

Peroxisome proliferation in cultured rat hepatocytes produced by clofibrate and phthalate ester metabolites.

T J Gray, J A Beamand, B G Lake, J R Foster, S D Gangolli.   

Abstract

Adult rat hepatocytes cultured for 48 h in the presence of 0.2 mM clofibrate, mono-(2-ethylhexyl)-phthalate (MEHP) or 2-ethylhexanol (2-EHA) contained increased numbers of peroxisomes. In keeping with the effects of these compounds in vivo, the peroxisome proliferation was associated with marked increases (up to 15-fold) in the activity of carnitine acetyltransferase. No such effects were produced by n-hexanol or two microsomal enzyme inducers, phenobarbital and 1,2-benzanthracene. These results suggest that cultured hepatocytes may provide a useful model system for studying chemically induced peroxisome proliferation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7080097     DOI: 10.1016/0378-4274(82)90087-x

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  11 in total

1.  On the compartmentalization of catalase, fatty acyl-CoA oxidase and urate oxidase in mammalian livers, and the influence of clofibrate treatment on this microlocalization.

Authors:  A Hemsley; M Pegg; D Crane; C Masters
Journal:  Mol Cell Biochem       Date:  1988-10       Impact factor: 3.396

Review 2.  Lipid-lowering drugs.

Authors:  K Pahan
Journal:  Cell Mol Life Sci       Date:  2006-05       Impact factor: 9.261

3.  Factors influencing peroxisome proliferation in cultured rat hepatocytes.

Authors:  A M Mitchell; J W Bridges; C R Elcombe
Journal:  Arch Toxicol       Date:  1984-10       Impact factor: 5.153

4.  Properties of peroxisomes and their induction by clofibrate in normal adult rat hepatocytes in primary culture.

Authors:  K Furukawa; Y Mochizuki; N Sawada
Journal:  In Vitro       Date:  1984-07

5.  Effect of very long chain fatty acids on peroxisomal beta-oxidation in primary rat hepatocyte cultures.

Authors:  E N Christiansen; T J Gray; B G Lake
Journal:  Lipids       Date:  1985-12       Impact factor: 1.880

6.  Plasticizer extraction of Taxol infusion solution from various infusion devices.

Authors:  B Mass; C Huber; I Krämer
Journal:  Pharm World Sci       Date:  1996-04

7.  Effects of the PPARα Agonist and Widely Used Antihyperlipidemic Drug Gemfibrozil on Hepatic Toxicity and Lipid Metabolism.

Authors:  Michael L Cunningham; Bradley J Collins; Milton R Hejtmancik; Ronald A Herbert; Gregory S Travlos; Molly K Vallant; Matthew D Stout
Journal:  PPAR Res       Date:  2010-10-04       Impact factor: 4.964

8.  Novel Phenoxazinones as potent agonist of PPAR-α: design, synthesis, molecular docking and in vivo studies.

Authors:  David I Ugwu; Uchechukwu C Okoro; Narendra K Mishra; Sunday N Okafor
Journal:  Lipids Health Dis       Date:  2018-05-22       Impact factor: 3.876

Review 9.  A reexamination of the PPAR-alpha activation mode of action as a basis for assessing human cancer risks of environmental contaminants.

Authors:  Kathryn Z Guyton; Weihsueh A Chiu; Thomas F Bateson; Jennifer Jinot; Cheryl Siegel Scott; Rebecca C Brown; Jane C Caldwell
Journal:  Environ Health Perspect       Date:  2009-05-15       Impact factor: 9.031

10.  Hepatic effects of phthalate esters and related compounds--in vivo and in vitro correlations.

Authors:  B G Lake; T J Gray; S D Gangolli
Journal:  Environ Health Perspect       Date:  1986-08       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.